RELATED CONTENT
NEWS
- UK govt offers "step change" in support for regenerative medicine
- BioSante to begin Phase I trial of melanoma vaccine at Johns Hopkins
- AMAG, Allos to merge – but will it really bring sales synergies for Feraheme, Folotyn?
- China must clean up act before it can join fully in global pharma, says KPMG report

